Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucinda M C Hall

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Microbiology (Reading, England)|September 2, 2006
Hypermutable bacteria isolated from humans--a critical analysisLucinda M C Hall, Stephanie K Henderson-Begg
International Journal of Antimicrobial Agents|April 15, 2004
Klebsiella pneumoniae isolate from South Africa with multiple TEM, SHV and AmpC beta-lactamasesSabiha Y Essack, Lucinda M C Hall, David M Livermore
Antimicrobial Agents and Chemotherapy|December 17, 2008
Plasmids imparting sulfonamide resistance in Escherichia coli: implications for persistenceDavid C Bean, David M Livermore, Lucinda M C Hall
The Journal of Antimicrobial Chemotherapy|March 15, 2006
Effect of subinhibitory concentrations of antibiotics on mutation frequency in Streptococcus pneumoniaeStephanie K Henderson-Begg, David M Livermore, Lucinda M C Hall
Antimicrobial Agents and Chemotherapy|May 23, 2002
Sulfonamide resistance in Haemophilus influenzae mediated by acquisition of sul2 or a short insertion in chromosomal folPVirve I Enne, Anna King, David M Livermore, et al.
Clinical and Vaccine Immunology : CVI|September 30, 2010
Streptococcus pneumoniae isolates expressing a capsule with epitopes of both serotypes 6A and 6BCarmen L Sheppard, Bruno Pichon, Robert C George, et al.
The Journal of Antimicrobial Chemotherapy|September 10, 2005
Resistance among Escherichia coli to sulphonamides and other antimicrobials now little used in manDavid C Bean, David M Livermore, Iro Papa, et al.
The Journal of Antimicrobial Chemotherapy|March 5, 2003
Variable susceptibility to piperacillin/tazobactam amongst Klebsiella spp. with extended-spectrum beta-lactamasesGioia S Babini, Meifang Yuan, Lucinda M C Hall, et al.
The Journal of Antimicrobial Chemotherapy|April 23, 2004
Enhancement of host fitness by the sul2-coding plasmid p9123 in the absence of selective pressureVirve I Enne, Peter M Bennett, David M Livermore, et al.
The Journal of Antimicrobial Chemotherapy|August 8, 2006
Mutators among CTX-M beta-lactamase-producing Escherichia coli and risk for the emergence of fosfomycin resistanceMatthew J Ellington, David M Livermore, Tyrone L Pitt, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Microbiology (Reading, England)|September 2, 2006
Hypermutable bacteria isolated from humans--a critical analysisLucinda M C Hall, Stephanie K Henderson-Begg
International Journal of Antimicrobial Agents|April 15, 2004
Klebsiella pneumoniae isolate from South Africa with multiple TEM, SHV and AmpC beta-lactamasesSabiha Y Essack, Lucinda M C Hall, David M Livermore
Antimicrobial Agents and Chemotherapy|December 17, 2008
Plasmids imparting sulfonamide resistance in Escherichia coli: implications for persistenceDavid C Bean, David M Livermore, Lucinda M C Hall
The Journal of Antimicrobial Chemotherapy|March 15, 2006
Effect of subinhibitory concentrations of antibiotics on mutation frequency in Streptococcus pneumoniaeStephanie K Henderson-Begg, David M Livermore, Lucinda M C Hall
Antimicrobial Agents and Chemotherapy|May 23, 2002
Sulfonamide resistance in Haemophilus influenzae mediated by acquisition of sul2 or a short insertion in chromosomal folPVirve I Enne, Anna King, David M Livermore, et al.
Clinical and Vaccine Immunology : CVI|September 30, 2010
Streptococcus pneumoniae isolates expressing a capsule with epitopes of both serotypes 6A and 6BCarmen L Sheppard, Bruno Pichon, Robert C George, et al.
The Journal of Antimicrobial Chemotherapy|September 10, 2005
Resistance among Escherichia coli to sulphonamides and other antimicrobials now little used in manDavid C Bean, David M Livermore, Iro Papa, et al.
The Journal of Antimicrobial Chemotherapy|March 5, 2003
Variable susceptibility to piperacillin/tazobactam amongst Klebsiella spp. with extended-spectrum beta-lactamasesGioia S Babini, Meifang Yuan, Lucinda M C Hall, et al.
The Journal of Antimicrobial Chemotherapy|April 23, 2004
Enhancement of host fitness by the sul2-coding plasmid p9123 in the absence of selective pressureVirve I Enne, Peter M Bennett, David M Livermore, et al.
The Journal of Antimicrobial Chemotherapy|August 8, 2006
Mutators among CTX-M beta-lactamase-producing Escherichia coli and risk for the emergence of fosfomycin resistanceMatthew J Ellington, David M Livermore, Tyrone L Pitt, et al.
Pageof 2